Login to Your Account



Solid Earnings For Amgen As Aranesp Hits $1B For Quarter

By Jennifer Boggs


Monday, July 24, 2006
Amgen Inc. soundly beat estimates for the second quarter, led by a boost in product revenue, including a 26 percent increase in sales of the anemia drug Aranesp. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription